IQVIA HOLDINGS INC. Reclassification from AOCI, Current Period, Tax
IQVIA HOLDINGS INC. (IQV) reported Reclassification from AOCI, Current Period, Tax of -$3.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ReclassificationFromAociCurrentPeriodTax · last filed 2026-05-05
- IQVIA HOLDINGS INC. reclassification from aoci, current period, tax for the quarter ending 2026-03-31 was -$3.00M.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, tax for the quarter ending 2025-12-31 was $1.00M.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, tax for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, tax for the quarter ending 2025-06-30 was $1.00M, a 75.00% decline year-over-year.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, tax for fiscal 2025 was $2.00M, a 80.00% decline from fiscal 2024.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, tax for fiscal 2024 was $10.00M, a 41.18% decline from fiscal 2023.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, tax for fiscal 2023 was $17.00M.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, tax for fiscal 2022 was -$2.00M.
| Period end | Reclassification from AOCI, Current Period, Tax 3 month | Reclassification from AOCI, Current Period, Tax 6 month | Reclassification from AOCI, Current Period, Tax 9 month | Reclassification from AOCI, Current Period, Tax 12 month | Reclassification from AOCI, Current Period, Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | -$3.00M 10-Q · filed 2026-05-05 | -$2.00M derived: sum of 2 quarters · filed 2026-05-05 | -$2.00M derived: sum of 3 quarters · filed 2026-05-05 | -$1.00M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.00M derived: sum of 2 quarters · filed 2026-02-17 | $2.00M derived: sum of 3 quarters · filed 2026-02-17 | $2.00M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.00M derived: sum of 2 quarters · filed 2025-10-28 | $1.00M 10-Q · filed 2025-10-28 | $1.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2025-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $1.00M 10-Q · filed 2025-07-22 | $1.00M derived: sum of 3 quarters · filed 2026-02-17 | $4.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $3.00M derived: sum of 3 quarters · filed 2026-02-17 | $7.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $3.00M derived: sum of 2 quarters · filed 2026-02-17 | $7.00M derived: sum of 3 quarters · filed 2026-02-17 | $10.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $7.00M derived: sum of 2 quarters · filed 2024-10-31 | $10.00M 10-Q · filed 2024-10-31 | $13.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | $7.00M 10-Q · filed 2024-07-22 | $10.00M derived: sum of 3 quarters · filed 2026-02-17 | $13.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | $3.00M 10-Q · filed 2024-05-02 | $6.00M derived: sum of 2 quarters · filed 2026-02-17 | $9.00M derived: sum of 3 quarters · filed 2026-02-17 | $12.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $6.00M derived: sum of 2 quarters · filed 2026-02-17 | $9.00M derived: sum of 3 quarters · filed 2026-02-17 | $17.00M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $6.00M derived: sum of 2 quarters · filed 2023-11-01 | $14.00M 10-Q · filed 2023-11-01 | $16.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $11.00M 10-Q · filed 2023-08-01 | $13.00M derived: sum of 3 quarters · filed 2025-02-13 | $13.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-03-31 | $8.00M 10-Q · filed 2023-04-28 | $10.00M derived: sum of 2 quarters · filed 2025-02-13 | $10.00M derived: sum of 3 quarters · filed 2025-02-13 | $6.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2022-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $2.00M derived: sum of 2 quarters · filed 2025-02-13 | -$2.00M derived: sum of 3 quarters · filed 2025-02-13 | -$2.00M 10-K · filed 2025-02-13 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$4.00M derived: sum of 2 quarters · filed 2022-10-27 | -$4.00M 10-Q · filed 2022-10-27 | -$6.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | -$4.00M 10-Q · filed 2022-07-22 | -$6.00M derived: sum of 3 quarters · filed 2024-02-15 | -$7.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-28 | -$2.00M derived: sum of 2 quarters · filed 2024-02-15 | -$3.00M derived: sum of 3 quarters · filed 2024-02-15 | -$3.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2021-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$3.00M derived: sum of 2 quarters · filed 2024-02-15 | -$3.00M derived: sum of 3 quarters · filed 2024-02-15 | -$4.00M 10-K · filed 2024-02-15 | |
| 2021-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | -$1.00M derived: sum of 2 quarters · filed 2021-10-22 | -$2.00M 10-Q · filed 2021-10-22 | -$3.00M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$1.00M 10-Q · filed 2021-07-28 | -$2.00M derived: sum of 3 quarters · filed 2023-02-15 | -$3.00M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-03-31 | -$1.00M 10-Q · filed 2021-04-23 | -$2.00M derived: sum of 2 quarters · filed 2023-02-15 | -$3.00M derived: sum of 3 quarters · filed 2023-02-15 | ||
| 2020-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$2.00M derived: sum of 2 quarters · filed 2023-02-15 | -$3.00M 10-K · filed 2023-02-15 | ||
| 2020-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | -$2.00M 10-Q · filed 2020-10-22 | |||
| 2020-06-30 | -$1.00M 10-Q · filed 2020-07-23 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-16 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$1.00M 10-Q · filed 2019-07-24 | |||
| 2019-03-31 | -$1.00M 10-Q · filed 2019-05-02 | ||||
| 2018-12-31 | -$1.00M 10-K · filed 2021-02-12 | $1.00M 10-K · filed 2019-02-19 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $1.00M 10-Q · filed 2018-07-27 | |||
| 2018-03-31 | $1.00M 10-Q · filed 2018-05-04 | ||||
| 2016-12-31 | $7.00M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |